Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035

Opportunities center on digitally connected, lab-grade lateral flow tests for decentralized care, particularly infectious disease, multiplex and CRISPR assays, recurring-use kits, and distribution through clinics, pharmacies, homes and e-commerce.

Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) — The “Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035” has been added to ResearchAndMarkets.com’s offering.

Global Lateral Flow Assay Market to Reach USD 17.66 Billion by 2035 as Point-of-Care Testing Expands

The global lateral flow assay market is projected to grow steadily as healthcare systems increase their adoption of rapid, decentralized diagnostic technologies. Valued at approximately USD 10.84 billion in 2025, the market is expected to reach USD 17.66 billion by 2035, registering a compound annual growth rate of 5.0% from 2026 to 2035.

Market expansion is being supported by rising demand for point-of-care testing, improvements in assay sensitivity, and the integration of digital connectivity into diagnostic platforms. These advances are helping lateral flow diagnostics deliver improved accuracy while maintaining the portability and operational efficiency required for use in hospitals, clinics, pharmacies, laboratories, and home care settings.

Market Growth Drivers

Healthcare providers worldwide are shifting toward decentralized diagnostic models following the COVID-19 pandemic. Hospitals and clinics are seeking technologies that reduce dependence on centralized laboratories, accelerate clinical decision-making, and improve patient flow. Lateral flow assay kits support these priorities by providing rapid results at or near the point of care, reducing delays in diagnosis and treatment.

Technological innovation is also strengthening the market outlook. In 2024, CRISPR-based lateral flow assays demonstrated sensitivity thresholds of 0.25 copy/?L, highlighting progress toward laboratory-level diagnostic performance in portable formats. Continued advances in assay design, reader technologies, multiplex detection, and digital result interpretation are expected to broaden clinical applications and improve diagnostic reliability.

Competitive Landscape and Market Developments

The lateral flow assay market includes major diagnostic companies such as Abbott, QuidelOrtho, Roche, Siemens Healthineers, Thermo Fisher Scientific, and Danaher Corporation. Established participants benefit from extensive research capabilities, global distribution networks, regulatory experience, and diversified diagnostic portfolios.

QuidelOrtho reported recurring revenue of USD 1.74 billion year-to-date in 2024, demonstrating the commercial strength of large diagnostic manufacturers. Leading companies are also positioned to manage complex regulatory processes, including FDA 510(k) clearance pathways, which have an average review period of approximately 168.9 days. Strong financial resources enable these organizations to sustain product development and regulatory investment while expanding their global market presence.

Market Challenges

Despite continued innovation, lateral flow assays may have lower sensitivity and specificity than laboratory-based methods such as polymerase chain reaction testing. Performance limitations can increase the risk of false-positive or false-negative results, potentially leading to unnecessary follow-up procedures, delayed diagnoses, or inappropriate treatment decisions. Manufacturers are addressing these concerns through enhanced reagents, digital readers, improved sample preparation, and advanced molecular detection technologies.

Lateral Flow Assay Market Segmentation

By product and service, lateral flow assay kits account for 71.9% of the market. Their leadership reflects recurring demand for disposable, single-use diagnostic strips across clinical, commercial, and home testing environments. Readers represent the remaining major product category and are becoming increasingly important as digital interpretation gains adoption.

Infectious disease testing holds a 72.2% market share by indication, supported by sustained demand for rapid detection during respiratory virus outbreaks and other infectious disease events. Additional indications include pregnancy testing and drug-of-abuse testing.

Sandwich assays represent nearly 48% of the market by technique, driven by their effectiveness in detecting proteins, biomarkers, and other high-molecular-weight analytes. Competitive assays and multiplex detection assays also contribute to market growth, with multiplex platforms attracting interest for their ability to identify multiple targets within a single testing workflow.

Hospitals and clinics lead the end-user segment with a 38.8% share as healthcare providers expand the use of rapid and multiplex diagnostic tools. Other end users include diagnostic laboratories, home care settings, pharmaceutical and biotechnology companies, and additional healthcare organizations.

Segment Breakdown

• Product and Services: Readers and lateral flow assay kits
• Indications: Infectious diseases, pregnancy testing, and drug-of-abuse testing
• Techniques: Sandwich assays, competitive assays, and multiplex detection assays
• End Users: Hospitals and clinics, diagnostic laboratories, home care settings, pharmaceutical and biotechnology companies, and others
• Distribution Channels: Hospital pharmacies, retail pharmacies, supermarkets and hypermarkets, and e-commerce platforms
• Regions: North America, Europe, Asia Pacific, the Middle East and Africa, and South America

North America Leads the Global Market

North America holds a 34.90% share of the global lateral flow assay market, with the United States serving as the region’s principal growth contributor. Regional leadership is supported by strong clinical demand, established healthcare infrastructure, regulatory pathways for diagnostic products, and the broad availability of point-of-care testing.

The United States records an estimated 40 million influenza cases annually and approximately 470,000 hospitalizations during recent flu seasons. This substantial disease burden reinforces the need for rapid diagnostic technologies that can support patient triage, treatment decisions, and healthcare resource management. Continued investment in infectious disease surveillance and decentralized testing is expected to sustain demand across the region.

Leading Market Participants

• Abbott Laboratories
• bioMerieux S.A.
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Hologic Inc.
• Merck KGaA
• PerkinElmer Inc.
• Qiagen N.V.
• QuidelOrtho Corporation
• Siemens Healthineers
• Thermo Fisher Scientific Inc.
• Other prominent market participants

The global lateral flow assay market is expected to benefit from continued innovation in portable diagnostics, growing demand for rapid infectious disease testing, and wider adoption of digitally connected point-of-care platforms. As manufacturers improve analytical performance and expand multiplex capabilities, lateral flow technologies are positioned to play an increasingly important role across clinical, laboratory, pharmacy, and home testing environments through 2035.

Key Attributes:

Key Topics Covered:

Chapter 1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

Chapter 2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation

Chapter 3. Executive Summary: Global Lateral Flow Assay Market
Executive Summary: Global Lateral Flow Assay Market

Chapter 4. Global Lateral Flow Assay Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Manufacturer
4.1.3. Service Provider
4.1.4. End-User
4.2. Industry Outlook
4.2.1. Various Applications of Point of Care Diagnostic Devices
4.3. PESTLE Analysis
4.4. Porter’s Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. COVID-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2020 – 2035
4.7.2. Price Trend Analysis, by product
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2025
4.8.3. Competitor Mapping

Chapter 5. Lateral Flow Assay Market Analysis, By Product & Services
5.1. Key Insights
5.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
5.2.1. Readers
5.2.1.1. Bench-top Readers
5.2.1.2. Hand-held Readers
5.2.2. LFA Kits
5.2.2.1. Test Strips
5.2.2.2. Dipsticks
5.2.2.3. Cassettes
5.2.2.4. Lancets

Chapter 6. Lateral Flow Assay Market Analysis, By Indications
6.1. Key Insights
6.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
6.2.1. Infectious Diseases
6.2.1.1. Mosquito-borne Diseases
6.2.1.2. Streptococcus Infections
6.2.1.3. Sexually Transmitted Diseases
6.2.1.4. Hepatitis
6.2.1.5. Tuberculosis
6.2.1.6. Asthma
6.2.1.7. Pneumonia
6.2.1.8. Sepsis
6.2.1.9. Gastrointestinal Infections
6.2.1.10. Others
6.2.2. Pregnancy Test
6.2.3. Drug of Abuse Testing

Chapter 7. Lateral Flow Assay Market Analysis, By Technique
7.1. Key Insights
7.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
7.2.1. Sandwich Assays
7.2.2. Competitive Assays
7.2.3. Multiplex Detection Assays

Chapter 8. Lateral Flow Assay Market Analysis, By End User
8.1. Key Insights
8.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
8.2.1. Hospitals & Clinics
8.2.2. Diagnostics Laboratories
8.2.3. Home Care Settings
8.2.4. Pharmaceuticals & Biotechnology Companies
8.2.5. Other

Chapter 9. Lateral Flow Assay Market Analysis, By Distribution Channel
9.1. Key Insights
9.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Supermarkets/Hypermarkets
9.2.4. e-Commerce

Chapter 10. Lateral Flow Assay Market Analysis, By Region
10.1. Key Insights
10.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
10.2.1. North America
10.2.1.1. The U.S.
10.2.1.2. Canada
10.2.1.3. Mexico
10.2.2. Europe
10.2.2.1. Western Europe
10.2.2.1.1. The UK
10.2.2.1.2. Germany
10.2.2.1.3. France
10.2.2.1.4. Italy
10.2.2.1.5. Spain
10.2.2.1.6. Rest of Western Europe
10.2.2.2. Eastern Europe
10.2.2.2.1. Poland
10.2.2.2.2. Russia
10.2.2.2.3. Rest of Eastern Europe
10.2.3. Asia Pacific
10.2.3.1. China
10.2.3.2. India
10.2.3.3. Japan
10.2.3.4. South Korea
10.2.3.5. Australia & New Zealand
10.2.3.6. ASEAN
10.2.3.7. Rest of Asia Pacific
10.2.4. Middle East & Africa
10.2.4.1. UAE
10.2.4.2. Saudi Arabia
10.2.4.3. South Africa
10.2.4.4. Rest of MEA
10.2.5. South America
10.2.5.1. Argentina
10.2.5.2. Brazil
10.2.5.3. Rest of South America

Chapter 11. North America Lateral Flow Assay Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
11.2.1. By Product & Services
11.2.2. By Indication
11.2.3. By Technique
11.2.4. By End User
11.2.5. By Distribution Channel
11.2.6. By Country

Chapter 12. Europe Lateral Flow Assay Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
12.2.1. By Product & Services
12.2.2. By Indication
12.2.3. By Technique
12.2.4. By End User
12.2.5. By Distribution Channel
12.2.6. By Country

Chapter 13. Asia Pacific Lateral Flow Assay Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
13.2.1. By Product & Services
13.2.2. By Indication
13.2.3. By Technique
13.2.4. By End User
13.2.5. By Distribution Channel
13.2.6. By Country

Chapter 14. Middle East and Africa Lateral Flow Assay Market Analysis
14.1. Key Insights
14.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
14.2.1. By Product & Services
14.2.2. By Indication
14.2.3. By Technique
14.2.4. By End User
14.2.5. By Distribution Channel
14.2.6. By Country

Chapter 15. South America Lateral Flow Assay Market Analysis
15.1. Key Insights
15.2. Market Size and Forecast, 2020 – 2035 (US$ Bn)
15.2.1. By Product & Services
15.2.2. By Indication
15.2.3. By Technique
15.2.4. By End User
15.2.5. By Distribution Channel
15.2.6. By Country

Chapter 16. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
16.1. Abbott Laboratories
16.2. bioMerieux S.A
16.3. Bio-Rad Laboratories Inc.
16.4. Danaher Corporation
16.5. F. Hoffmann-La Roche Ltd.
16.6. Hologic Inc.
16.7. Merck KGaA
16.8. PerkinElmer Inc.
16.9. Qiagen N.V.
16.10. Quidel Corporation
16.11. Siemens Healthineers
16.12. Thermo Fisher Scientific, Inc.,
16.13. Other Prominent Players

A selection of companies mentioned in this report includes, but is not limited to:

• Abbott Laboratories
• bioMerieux S.A
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Hologic Inc.
• Merck KGaA
• PerkinElmer Inc.
• Qiagen N.V.
• Quidel Corporation
• Siemens Healthineers
• Thermo Fisher Scientific, Inc.,

For more information about this report visit https://www.researchandmarkets.com/r/fth0kw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Lateral Flow Assay Market

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900